IDEAYA Biosciences, Inc. (IDYA)
NASDAQ: IDYA · Real-Time Price · USD
24.86
-0.16 (-0.64%)
At close: Jul 29, 2025, 4:00 PM
24.84
-0.02 (-0.08%)
After-hours: Jul 29, 2025, 5:07 PM EDT
IDEAYA Biosciences Market Cap
IDEAYA Biosciences has a market cap or net worth of $2.18 billion as of July 29, 2025. Its market cap has decreased by -34.61% in one year.
Market Cap
2.18B
Enterprise Value
1.15B
1-Year Change
-34.61%
Ranking
Category
Stock Price
$24.86
Market Cap Chart
Since May 23, 2019, IDEAYA Biosciences's market cap has increased from $215.57M to $2.18B, an increase of 910.03%. That is a compound annual growth rate of 45.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 28, 2025 | 2.19B | -1.35% |
| Dec 31, 2024 | 2.22B | -3.15% |
| Dec 29, 2023 | 2.29B | 162.34% |
| Dec 30, 2022 | 874.22M | -3.92% |
| Dec 31, 2021 | 909.90M | 123.69% |
| Dec 31, 2020 | 406.77M | 168.50% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 23, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 729.58B |
| Johnson & Johnson | 405.32B |
| AbbVie | 336.11B |
| Novo Nordisk | 315.59B |
| UnitedHealth Group | 254.96B |
| Novartis AG | 225.74B |
| AstraZeneca | 225.08B |
| Abbott Laboratories | 220.16B |